Skip to main content

Your search for “NIH Director” returned 211 results

National Clinical Trial Launches, Will Test Promising Vaccine Against Novel Coronavirus

July 24, 2020

UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.

Elizabeth Villa Selected as 2021 HHMI Investigator

September 23, 2021

Biological Sciences Associate Professor Elizabeth Villa has been selected as a 2021 Howard Hughes Medical Institute (HHMI) Investigator. As one of 33 scientists chosen out of pool of more than 800, Villa will receive $9 million over a seven-year HHMI Investigator term.

Scientists Look Deeper to See How RNA-editing Enzyme Evolved into a Genome Editor

March 6, 2020

A team of chemists and biochemists at UC San Diego used a combination of computational simulations and experiments to deepen understanding of the latest genome editing technology.

Excess Protein Linked to Development of Parkinson’s Disease

February 7, 2013

Researchers at the University of California, San Diego School of Medicine say overexpression of a protein called alpha-synuclein appears to disrupt vital recycling processes in neurons, starting with the terminal extensions of neurons and working its way back to the cells’ center, with the potential consequence of progressive degeneration and…

Paradox of Aging: The Older We Get, the Better We Feel?

December 7, 2012

Aging has been viewed as a period of progressive decline in physical, cognitive and psychosocial functioning, and is viewed by many as the “number one public health problem” facing Americans today. This negative view of aging contrasts with results of a comprehensive study of 1,006 older adults in San Diego…

Stem Cells, CRISPR and Gene Sequencing Technology are Basis of New Brain Cancer Model

January 28, 2020

University of California San Diego School of Medicine researchers created a new type of brain cancer model for glioblastoma using stem cells, CRISPR and gene sequencing.

An Entirely New COVID-Related Syndrome

May 9, 2024

A group of UC San Diego researchers, centered at UC San Diego’s Institute for Network Medicine, teamed up with rheumatologists at the University of Leeds in the United Kingdom to solve a medical mystery.

New Grant Will Fund Collaborative Effort to Build Reproducible Assays To Model Autism

September 22, 2015

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk…

Arrhythmia Mapping Technology Demonstrates Positive Clinical Results

May 4, 2022

Bioengineers and cardiologists from UC San Diego invented a technology that can accurately and noninvasively map atrial and ventricular heart arrhythmias in a matter of minutes. The technology demonstrated 97.3 percent accuracy in a clinical validation study, and recently received FDA clearance.

Researchers Discover Specific Tumor Environment That Triggers Cells to Metastasize

November 21, 2017

A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells are confined in a dense environment, the researchers found that they turn on a specific set of genes…

Category navigation with Social links